Human UC‐MSC‐Exos significantly alleviated IBD symptoms in mice by increasing the gene expression levels of TNF‐α, IL‐1β, IL‐6, NAe1, E2M, and Uba3. Here, UBA3 is linked to inflammatory bowel disease.